VENTURE LIFE GROUP PLC Logo

VENTURE LIFE GROUP PLC

Develops, manufactures, and distributes consumer self-care products and medical devices globally.

VLG | IL

Overview

Corporate Details

ISIN(s):
GB00BFPM8908 (+2 more)
LEI:
213800S8CZUPLAB2KC70
Country:
United Kingdom
Address:
12 THE COURTYARD, RG12 2XB BRACKNELL
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Venture Life Group PLC is an international consumer self-care company that develops, manufactures, and distributes products for the global market. The company's portfolio focuses on non-prescription items, including medical devices and food supplements, designed to meet the growing demand for preventative wellness and self-medication. It operates an extensive distribution network with over 200 partners in more than 90 countries. Key brands in its portfolio include Earol® and EarolSwim®, which provide clinically proven ENT care solutions. Venture Life's business model is centered on commercializing products that address the needs of an aging population and respond to pressures on global healthcare budgets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 08:15
Transaction in Own Shares
Transaction in Own Shares
English 17.8 KB
2025-11-20 08:20
Transaction in Own Shares
Transaction in Own Shares
English 17.8 KB
2025-11-19 08:20
Transaction in Own Shares
Transaction in Own Shares
English 17.3 KB
2025-11-18 08:15
Transaction in Own Shares
Transaction in Own Shares
English 17.2 KB
2025-10-03 17:40
Director's Dealing
Director/PDMR Shareholding
English 22.3 KB
2025-09-30 08:01
Transaction in Own Shares
Share Buyback Programme
English 14.1 KB
2025-09-29 13:19
Report Publication Announcement
Investor Presentation via Investor Meet Company
English 9.6 KB
2025-09-24 15:38
Report Publication Announcement
Change of Accounting Reference Date
English 10.4 KB
2025-09-08 08:00
Board/Management Information
Directorate Change
English 11.5 KB
2025-08-19 15:04
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-08-05 16:43
Post-Annual General Meeting Information
Result of General Meeting
English 10.1 KB
2025-07-07 17:21
Director's Dealing
Director/PDMR Shareholding
English 22.1 KB
2025-07-03 08:00
Director's Dealing
Director Dealings
English 55.5 KB
2025-07-02 08:00
Pre-Annual General Meeting Information
Notice of General Meeting & Investor Presentation
English 11.8 KB
2025-07-01 17:08
Major Shareholding Notification
Holding(s) in Company
English 53.0 KB

Automate Your Workflow. Get a real-time feed of all VENTURE LIFE GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VENTURE LIFE GROUP PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VENTURE LIFE GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.